Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast as a controller of atopic syndrome (MONTAS)
2007-000047-99Phase 4Completed
- Sponsor
- Tari Haahtela
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of montelukast in allergic rhinitis (AR), allergic conjunctivitis (AC), asthma and 2 more, sponsored by Tari Haahtela. Primary endpoint: Allergic symptom score. Started Jan 2007; status: completed.
02
Drugs
montelukast
03
Conditions
allergic rhinitis (AR)allergic conjunctivitis (AC)asthmaatopic dermatitis (AD)pollinosis
Beyond the preview
Go deeper on 2007-000047-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000047-99.